Detalhe da pesquisa
1.
Pathogenic BRCA1 mutations may be necessary but not sufficient for tissue genomic heterogeneity: Deep sequencing data from ovarian cancer patients.
Gynecol Oncol
; 152(2): 375-386, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446274
2.
Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
BMC Cancer
; 17(1): 124, 2017 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28193205
3.
Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers.
Front Oncol
; 14: 1328512, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38444675
4.
Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer.
PLoS One
; 17(2): e0262770, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130283
5.
ALK alterations in salivary gland carcinomas.
Virchows Arch
; 478(5): 933-941, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33237469
6.
Multisite Tumor Sampling Reveals Extensive Heterogeneity of Tumor and Host Immune Response in Ovarian Cancer.
Cancer Genomics Proteomics
; 17(5): 529-541, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32859631
7.
Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers.
Am J Cancer Res
; 8(1): 2-15, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29416916
8.
Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer.
PLoS One
; 13(12): e0208221, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30521558
9.
Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping.
Med Oncol
; 35(7): 101, 2018 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29855806
10.
Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts.
Cancer Discov
; 8(5): 600-615, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29483136
11.
Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens.
J Thorac Oncol
; 12(10): 1503-1511, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28751246
12.
Interaction Between Beta-Catenin and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast Cancer.
Anticancer Res
; 36(5): 2365-78, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27127145
13.
Immunohistochemical study of immunological markers: HLAG, CD16, CD25, CD56 and CD68 in placenta tissues in recurrent pregnancy loss.
Histol Histopathol
; 29(8): 1047-55, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24557735
14.
Detection of Discrepant Driver Mutations in a Patient with Two Synchronous Primary Non-Small Cell Lung Cancers (NSCLCs) with Liquid Biopsy.
J Thorac Oncol
; 12(11): e186-e188, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29074212
15.
Crizotinib Failure in a TPM4-ALK-Rearranged Inflammatory Myofibroblastic Tumor With an Emerging ALK Kinase Domain Mutation.
JCO Precis Oncol
; 1: 1-7, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172497
16.
Low expression of progesterone receptor A in intermediate trophoblast of miscarriages.
Histol Histopathol
; 26(5): 609-14, 2011 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-21432776
17.
A Novel EGFR(C797) Variant Detected in a Pleural Biopsy Specimen from an Osimertinib-Treated Patient Using a Comprehensive Hybrid Capture-Based Next-Generation Sequencing Assay.
J Thorac Oncol
; 11(9): e105-7, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27086175